Long-Term Data Collection From Participants in Adult AIDS Clinical Trials
Sponsored by AIDS Clinical Trials Group
About this trial
Last updated 12 years ago
Study ID
ACTG A5001
Status
Completed
Type
Observational
Placebo
No
Accepting
13+ Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 12 years ago
What is this trial about?
The purpose of this study is to determine what combinations of anti-HIV drugs work best in
patients treated over several years. The study will also assess the occurrence of side
effects and opportunistic infections in patients with low viral loads compared to those with
higher viral loads.
What are the participation requirements?
Inclusion Criteria
- HIV-1 infected
- Enrolled in an AIDS Clinical Trial Group (ACTG) parent study and has enrolled in this study on or before the Week 16 visit of the parent study, including the visit window of the parent study. More information on this criterion can be found in the protocol.
- Willing to provide consent for the release and use of clinical data from the parent study
- Life expectancy of at least 24 weeks
- Parent or guardian willing to provide informed consent, if applicable
Exclusion Criteria
- Active alcohol or drug abuse that may interfere with the study